Lifesci Capital Has Pessimistic View of ATXS FY2025 Earnings
Astria Therapeutics, Inc. (NASDAQ:ATXS – Free Report) – Stock analysts at Lifesci Capital cut their FY2025 earnings per share estimates for Astria Therapeutics in a research report issued to clients and investors on Tuesday, March 11th. Lifesci Capital analyst S. Slutsky now anticipates that the biotechnology company will post earnings per share of ($1.97) for […]
Astria Therapeutics, Inc. (NASDAQ:ATXS – Free Report) – Stock analysts at Lifesci Capital cut their FY2025 earnings per share estimates for Astria Therapeutics in a research report issued to clients and investors on Tuesday, March 11th. Lifesci Capital analyst S. Slutsky now anticipates that the biotechnology company will post earnings per share of ($1.97) for […]
